Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10197 |
| Vaccine Name | MVA-MERS-S_DF1 |
| Disease Name | MERS |
| Disease Classification | Respiratory |
| Virus Name | MERS-CoV |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Recombinant viral vector |
| Vaccine Status | Phase 1 |
| Manufacturer | CTC North GmbH & Co. KG |
| Year of Manufacturing | 2021 |
| Manufacturing Country | Germany |
| Age | 18 - 55 years |
| Dosage | NA |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | MERS CoV spike glycoprotein |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | 33341119 |
| Clinical Trial ID | NCT04119440 |
| Reference Link | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749790/ |
| Additional Links | NA |